Neogen (NEOG) Return on Capital Employed Growth (1y) (2012 - 2026)
Neogen (NEOG) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 125.00 |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | 41,258.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 41,258.00 |
| Nov 30, 2025 | 262.00 |
| Aug 31, 2025 | -3,406.00 |
| May 31, 2025 | -6,302.00 |
| Feb 28, 2025 | -43,395.00 |
| Nov 30, 2024 | -2,374.00 |
| Aug 31, 2024 | -14.00 |
| May 31, 2024 | 47.00 |
| Feb 29, 2024 | 83.00 |
| Nov 30, 2023 | 78.00 |
| Aug 31, 2023 | -353.00 |
| May 31, 2023 | -559.00 |
| Feb 28, 2023 | -597.00 |
| Nov 30, 2022 | -704.00 |
| Aug 31, 2022 | -412.00 |
| May 31, 2022 | 15.00 |
| Feb 28, 2022 | 21.00 |
| Nov 30, 2021 | 154.00 |
| Aug 31, 2021 | 234.00 |
| May 31, 2021 | -828.00 |